A new form of Epstein-Barr virus latency in vivo.
Miyashita
E
E
Dept. of Pathology, Tufts University School of Medicine, Boston, MA 02111.
Thorley-Lawson
D A
DA
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D016175:B-Lymphocyte Subsets / Q000821:virology*; D002461:Cell Line, Transformed; D004279:DNA, Viral / Q000032:analysis; D016679:Genome, Viral; D006566:Herpesviridae Infections / Q000821:virology*; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D006801:Humans; D016867:Immunocompromised Host; D009000:Monocytes / Q000821:virology; D010641:Phenotype; D016133:Polymerase Chain Reaction; D017455:Receptors, IgE / Q000032:analysis; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014412:Tumor Virus Infections / Q000821:virology*; D014766:Viremia / Q000821:virology*; D017735:Virus Latency
D000914:Antibodies, Viral; D004279:DNA, Viral; D017455:Receptors, IgE